Conversely, if GLP-1s are increasing longevity in patients due to reducing the risk factors associated with certain diseases, the increased lifespan may result in increased dental treatments
Because intense pharma competition weight loss drugs combined with policy pressure is forcing manufacturers to prioritize patient volume over a high list price
PPIs are drugs taken for GERD (gastro-esophageal reflux disease) like omeprazole (Prilosec brand name), esomeprazole (Nexium), and lansoprazole (Prevacid) that block the secretion of stomach acid
and the last group received a placebo
False negative: the test result is negative, but the person does have the disease
10.1111/dom.16364 Summary Keywords tirzepatide, rhabdomyolysis, GLP-1 receptor agonist, adverse drug reaction, muscle injury Citation Bodanowitz JM, Mattes I, Loebermann M and Fritzsche C (2025) Case Report: Rhabdomyolysis following initiation of tirzepatide